Martek to Present at Upcoming Citi Small / Mid Cap Conference
Share:
COLUMBIA, Md., Nov. 3, 2010 -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the 2010 Citi Small / Mid Cap Conference being held on November 16-17, 2010 in Las Vegas, NV. Steve Dubin, Chief Executive Officer is scheduled to present on Tuesday, November 16 at 10:15 a.m. Pacific Time (1:15 p.m. Eastern Time). A live audio webcast of the presentation can be accessed at: http://www.veracast.com/webcasts/citigroup/smidcap2010/42104135.cfm
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition. The company's technology platform consists of its core expertise, broad experience and proprietary technology in areas such as microbial biology, algal genomics, fermentation and oil processing. This technology platform has resulted in Martek's development of a number of products including the company's flagship product, life'sDHA(TM), a sustainable and vegetarian source of algal DHA (docosahexaenoic acid) important for brain, heart and eye health throughout life for use in infant formula, pregnancy and nursing products, foods and beverages and dietary supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula and growing-up milks. Martek's subsidiary, Amerifit Brands, develops, markets and distributes branded consumer health and wellness products and holds leading brand positions in all of its key product categories. Amerifit products are sold in most major mass, club, drug, grocery and specialty stores and include: Culturelle®, a leading probiotic supplement; AZO, the leading OTC brand addressing symptom relief, detection and prevention of urinary tract infections; and ESTROVEN®, the leading all-natural nutritional supplement brand addressing the symptoms of menopause. Martek currently has a number of nutritional health and wellness products under development that it plans to commercialize and distribute through Amerifit's distribution channels.
Martek's technology platform has also made it a sought-after partner on a range of groundbreaking projects in process, including the development of microbially-derived biofuels and the development of DHA-containing oilseeds. For more information on Martek Biosciences, visit www.martek.com/. For a complete list of life'sDHA and life'sARA products, visit www.lifesdha.com/. For more information about Amerifit Brands, visit www.amerifit.com.
SOURCE Martek Biosciences Corporation
CONTACT:Kyle Stults,Investor Relations,+1-410-740-0081,investors@martek.com
Web Site: www.martek.com
